Global

Healthcare Experts

Hans H. Zingg

Professor
Division of Endocrinology & Metabolism
McGill University
Canada

Biography

Dr. Zingg received his MD in 1973 at the University of Basel and his Ph.D. at McGill under the guidance of the late Dr. Y. C. Patel. After a postdoctoral fellowship at Harvard Medical School with Dr. Joel Habener, he was recruited back to McGill where he rose to the ranks of Full Professor of Medicine, Pharmacology and Obstetrics & Gynecology. Prior to being Chairman of the Department of Pharmacology and Therapeutics, he was Director of the Laboratory of Molecular Endocrinology at the Royal Victoria Hospital and Associate Director, Fundamental Research, of the MUHC Research Institute. He was the holder of a Wyeth-Ayerst Clinical Research Chair, a Distinguished Scientist Award from the Canadian Society for Clinical Investigations and a Senior Scientist Award from the CIHR. He is a member of the American Association of Physicians (AAP).

Research Interest

Research contributions include the discovery of a novel paracrine oxytocin system in the uterus, novel direct interactions between steroid hormones and peptide hormone receptors, cloning of the rat oxytocin receptor gene, characterization of oxytocin receptor-associated signaling mechanisms and discovery of novel genes expressed in the uterus. Dr. Zingg is actively involved in teaching medical students basic concepts in endocrinology and selected clinical skills. He is also seeing patients at the Metabolic Day Centre of the MUHC.

Publications

  • Murat B, Devost D, Andres M, Mion J, Boulay V, Corbani M, Zingg HH, Guillon G 2012 V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH. Molecular Endocrinology 26:502-20, Elected to the Faculty of 1000 (http://f1000.com/714897825)

  • Goupil E, Tassy D, Bourguet C, Quiniou C, Wisehart V, Pétrin D, Le Gouill C, Devost D, Zingg HH, Bouvier M, Saragovi HU, Chemtob S, Lubell WD, Claing A, Hébert TE, Laporte SA. 2010 A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway. J Biol Chem.285:25624-36.

  • Devost D., Carrier M-E, and Zingg H.H. 2008 Oxytocin-induced activation of eukaryotic elongation factor eEF2 in myometrial cells is mediated by protein kinase C. Endocrinology 149:131-138.

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America